Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (171-180 of 508) with videos related to

Pageof 51
Sort By:
BMJ Open|February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) studyDavid A Rorie, Amy Rogers, Isla S Mackenzie, et al.
The American Journal of Medicine|January 23, 2017
Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery DiseasePaul R Kalra, Nicola Greenlaw, Roberto Ferrari, et al.
European Journal of Heart Failure|March 25, 2015
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudyMichael Böhm, Jeffrey S Borer, John Camm, et al.
International Journal of Epidemiology|October 28, 2008
Adipocytokines and risk of stroke in older people: a nested case-control studyDavid J Stott, Paul Welsh, Ann Rumley, et al.
European Heart Journal|August 21, 2018
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registryEmmanuelle Vidal-Petiot, Emmanuel Sorbets, Deepak L Bhatt, et al.
European Journal of Heart Failure|March 9, 2016
Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFTMichael Böhm, Suzanne M Lloyd, Ian Ford, et al.
American Heart Journal|October 8, 2013
Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trialColin Berry, Jamie Layland, Arvind Sood, et al.
European Journal of Preventive Cardiology|December 1, 2016
Relationship between outdoor temperature and cardiovascular disease risk factors in older peopleClaudio Sartini, Sarah Je Barry, Peter H Whincup, et al.
Aging Clinical and Experimental Research|October 14, 2016
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertensionMaryam Barma, Faisel Khan, Rosemary J G Price, et al.
American Journal of Hypertension|July 10, 2015
Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old AgeLiselotte W Wijsman, Anton J M de Craen, Majon Muller, et al.
Pageof 51

Showing results (171-180 of 508) with videos related to

Sort By:
Pageof 51
BMJ Open|February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) studyDavid A Rorie, Amy Rogers, Isla S Mackenzie, et al.
The American Journal of Medicine|January 23, 2017
Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery DiseasePaul R Kalra, Nicola Greenlaw, Roberto Ferrari, et al.
European Journal of Heart Failure|March 25, 2015
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudyMichael Böhm, Jeffrey S Borer, John Camm, et al.
International Journal of Epidemiology|October 28, 2008
Adipocytokines and risk of stroke in older people: a nested case-control studyDavid J Stott, Paul Welsh, Ann Rumley, et al.
European Heart Journal|August 21, 2018
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registryEmmanuelle Vidal-Petiot, Emmanuel Sorbets, Deepak L Bhatt, et al.
European Journal of Heart Failure|March 9, 2016
Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFTMichael Böhm, Suzanne M Lloyd, Ian Ford, et al.
American Heart Journal|October 8, 2013
Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trialColin Berry, Jamie Layland, Arvind Sood, et al.
European Journal of Preventive Cardiology|December 1, 2016
Relationship between outdoor temperature and cardiovascular disease risk factors in older peopleClaudio Sartini, Sarah Je Barry, Peter H Whincup, et al.
Aging Clinical and Experimental Research|October 14, 2016
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertensionMaryam Barma, Faisel Khan, Rosemary J G Price, et al.
American Journal of Hypertension|July 10, 2015
Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old AgeLiselotte W Wijsman, Anton J M de Craen, Majon Muller, et al.
Pageof 51